Press release
Bioresorbable magnesium implants from Syntellix approved in Colombia / Australia grants approval for coated MAGNEZIX® CSc bone screw
Hanover, June 10, 2021. The Colombian Ministry of Health Minsalud has approved the use of bioresorbable magnesium implants for the surgical stabilization of bones. This enables Syntellix AG to launch its successful MAGNEZIX® CS ("Compression Screws") product family in Latin America's fourth largest economy. After overcoming the Corona crisis, its medical technology market will grow at an above-average rate to 1.6 billion US dollars by 2024, according to a forecast by Germany Trade & Invest, the economic devel-opment agency of the Federal Republic of Germany. Colombia is the 69th country in which Syntellix has achieved regulatory approval, following recent additions of Brazil and the Philippines. Good news also from Australia, where the health authority is extending the approval already in place since 2016 to include the ceramized MAGNEZIX® CSc 4.8, the largest dimension in the CS range to date.In orthopedics and trauma surgery, compression screws made of the patent-protected alloy MAGNEZIX® are used to fix small and medium-sized bones after an accident or to correct a malposition. The highlight: The implant is as stable as comparable products made of titanium and "transforms" into bone in due course. This eliminates the need for surgery to remove common metal implants, which is often necessary, and thus prevents the risk of infection, for example from hospital germs.
The product will be marketed in Colombia by a local distribution partner. The country is home to over 50 million people, and top hospitals enjoy an excellent reputation beyond the country's borders. "The Colombian market is particularly exciting," comments Syntel-lix Chief Medical Officer Prof. Dr. Martin Kirschner, "because healthcare providers are very progress-oriented and patients place a particularly high value on innovative and state-of-the-art products."
Aegidientorplatz 2a
30159 Hannover
Michael Blum
+49 511 270 413 50
presse@syntellix.com
Syntellix AG, a multi-award-winning global pioneer in Biomedical Engineering, Materials & Life Science, is the worldwide market leader in the field of bioabsorbable magnesium-based metallic orthopedic implants. Currently, about 40 medical-scientific publications prove the safety, efficacy and reliability of the MAGNEZIX® implants developed by Syntel-lix, which are described as "advantageous" or even "clinically superior" to conventional titanium implants for numerous clinical applications.
www.syntellix.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioresorbable magnesium implants from Syntellix approved in Colombia / Australia grants approval for coated MAGNEZIX® CSc bone screw here
News-ID: 2302647 • Views: …
More Releases from Syntellix AG
Russia opens its market for bioabsorbable Syntellix implants: Now approved in 70 …
The Russian health authority Roszdravnadzor has approved the use of magnesium-based bioabsorbable implants from the German biomedical & biomaterials pioneer Syntellix. This means that the company's international sales department is now also opening up the market in the largest country in the world in terms of surface area, building on an already existing partnership with a specialized national importer and distributor.
The compression screws and pins, which have now been officially…
Approval at the Sugarloaf Mountain: Bioabsorbable MAGNEZIX® CBS approved for me …
Hanover, 31 May 2021 – Syntellix AG has reached another important milestone in the context of its global footprint strategy: The Brazilian health authority ANVISA has approved the product family MAGNEZIX® CBS with 2.7-milimetre and 3.5-milimetre diameter. The cortical screws developed, and distributed by Syntellix can now be used for the surgical treatment of small and large bone fragments in the world's fifth largest country by area and sixth most…

World market leader for magnesium implants in orthopaedic and trauma surgery str …
Helge Hentschel, Jan-Marten Seitz promoted to C Level / Michael Blum Head of Communications:
Hanover, 25 February 2021. Helge Hentschel and Dr Jan-Marten Seitz are now part of the top management of Syntellix AG: Hentschel rises to the new position of Chief Legal and Accounting Officer, Seitz to Chief Technical Officer. Prof Utz Claassen, founder and CEO of the world's leading provider of metal-based bioresorbable implants for orthopaedic and trauma…
Philippines becomes the 67th country to approve MAGNEZIX® products
Syntellix, the world's leading supplier of highly innovative magnesium-based implants for orthopaedics and trauma surgery, has reached another important milestone. The Philippine Food and Drug Administration (FDA) has granted Syntellix AG the registration of the full MAGNEZIX® CBS screw portfolio, making the Philippines the 67th country that allows for import and sale of MAGNEZIX® implants. Having this at hand, Syntellix is enthusiastic to scale up its business operations, bundled in…
More Releases for MAGNEZIX®
Punch!® Software Releases Punch!CAD™ SharkCAD® & ViaCAD® 15
NOVATO, Calif., December 10, 2024 - Punch!® Software, a leading software developer of Home Design and CAD titles for over 25 years, today announced the release of new Windows and Mac versions of the SharkCAD® 15 and ViaCAD® 15 family of products.
This latest release encompasses a range of variants for the Windows and Macintosh platform: SharkCAD® Pro, SharkCAD®, ViaCAD® Pro, ViaCAD® 2D/3D, and ViaCAD® 2D.
Punch!CAD™ products continue to provide innovative…
Ultimate Chemicals® Featured in Manufacturing Marvels® on The Fox Business Net …
MOORE, OK., Oct. 8, 2021/ -- Ultimate Chemicals® Inc., an integrated manufacturer and supplier of chemicals and related services, is pleased to announce it will be showcased in a broadcast of Manufacturing Marvels® scheduled to air on October 14, 2021 at approximately 9:30-9:44 p.m. EST on The Fox Business Network® (FBN).
Ultimate Chemicals has created their products to help restore surfaces to their optimum surface capability. Non-destructive to the surfaces to…
Approval at the Sugarloaf Mountain: Bioabsorbable MAGNEZIX® CBS approved for me …
Hanover, 31 May 2021 – Syntellix AG has reached another important milestone in the context of its global footprint strategy: The Brazilian health authority ANVISA has approved the product family MAGNEZIX® CBS with 2.7-milimetre and 3.5-milimetre diameter. The cortical screws developed, and distributed by Syntellix can now be used for the surgical treatment of small and large bone fragments in the world's fifth largest country by area and sixth most…
Philippines becomes the 67th country to approve MAGNEZIX® products
Syntellix, the world's leading supplier of highly innovative magnesium-based implants for orthopaedics and trauma surgery, has reached another important milestone. The Philippine Food and Drug Administration (FDA) has granted Syntellix AG the registration of the full MAGNEZIX® CBS screw portfolio, making the Philippines the 67th country that allows for import and sale of MAGNEZIX® implants. Having this at hand, Syntellix is enthusiastic to scale up its business operations, bundled in…
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA and Intelligent Enterprise to Manufacturing, Consumer Products, Higher education, and research, Industrial machinery and components, Life sciences and Automotive Industries
Chicago, IL, June 10, 2020 – Sunera Technologies, Inc announced that it had joined the SAP® PartnerEdge® program as a Re-sell & Services partner, through which it will resell SAP solutions to midsize organizations in North America. Through this engagement, SuneraTech…
American Megatrends Announces AMIBIOS®8 & Aptio®4.x Support for the Intel® Xe …
ATLANTA, GEORGIA - American Megatrends (AMI) is pleased to announce that its AMIBIOS®8 & Aptio®4.x products feature support for the new Intel® Xeon® 5500 Platform.
The Intel® Xeon® 5500 platform combines the Intel® Xeon® Processor 5500 Series with the Intel® 5520 Chipset for embedded, storage, security and communications infrastructure applications in a wide range of form factors. There are four different processor options for this platform with seven year lifecycle support…